User Success Stories
User Success Stories
Click a name below to view their story, or browse all stories to the right.
-
Kelly Thompson, Esq.
Health Policy Expert
-
Laura Thomas, MPH, MPP
Deputy State Director, California, of the Drug Policy Alliance
-
Alessandra Ross, MPH
Injection Drug Use Specialist
-
Bryce Pardo, PhD
Associate Director, Drug Policy Research Center; Policy Researcher
-
Benjamin Mason Meier, JD, LLM, PhD
Professor of global health policy in the Dept. of Public Policy and the Dept. of Health Policy and Mgmt. at the University of North Carolina–Chapel Hill
-
Darrell Klein, JD
Deputy Director of Public Health Nebraska DHHS at State of Nebraska
-
Manel Kappagoda, JD, MPH
Program Director and Senior Staff Attorney ChangeLab Solutions Oakland, CA
-
Emalie Huriaux, MPH
Integration, Hepatitis C, and Drug User Health Program Manager for the Washington State Department of Health
-
Rachel Hulkower, JD, MSPH
Public Health Analyst at Centers for Disease Control and Prevention
-
Micah Berman, JD
Associate professor of public health and law at The Ohio State University's College of Public Health and Michael E. Moritz College of Law
-
Maya Doe-Simkins, MPH
Public health educator, researcher and consultant
-
Nabarun Dasgupta, MPH, PhD
Epidemiologist at the University of North Carolina–Chapel Hill
Kelly Thompson, Esq.
In our work, we build datasets from scratch to understand the legal landscape for issues related to our field, state by state.
Policy surveillance is important because it creates more transparency between lawmakers and the people who are actually impacted by the laws they pass. It’s important at a legislative level to understand what jurisdictions are doing, and outcomes, before making decisions in your own jurisdiction.
Laura Thomas, MPH, MPP
I’m an advocate who primarily works at the state level, and one of the things that state legislators are always interested in — good and bad — is how they compare to others states. Being able to show California legislators where California stands in relation to other states can be a useful motivator because it puts our policy proposals in context.
Alessandra Ross, MPH
Bryce Pardo, PhD
Benjamin Mason Meier, JD, LLM, PhD
Darrell Klein, JD
My office, at the Nebraska Department of Health and Human Services, participated in an RWJF-funded project to assess
Manel Kappagoda, JD, MPH
I was an RWJF Public Health Law Research program grantee.
Emalie Huriaux, MPH
My organization does community education and some policy work in California and nationwide on issues related to HIV/A
Rachel Hulkower, JD, MSPH
We used LawAtlas to collect and catalog Medicaid prior-authorization polices related to prescriptions for children with ADHD for CDC’s National Center on Birth Defects and Developmental Disabilities. We were interested in comparing the legal landscape with Medicaid reimbursement rates to see if prior-authorization policies could potentially impact prescriber behavior based on academic recommendations.
Micah Berman, JD
Maya Doe-Simkins, MPH
"It’s helpful to have these resources to point out where ideas exist elsewhere, or not; or to show a critical mass to assure a policymaker that they’re not stepping into uncharted territory."
In our work at Prescribe to Prevent, we provide a lot of technical assistance to small agencies, underground initiatives and state-level government agencies working on overdose initiatives. LawAtlas is a resource I always check whenever I’m trying to answer questions.
Nabarun Dasgupta, MPH, PhD
I was an RWJF Public Health Law Research program grantee. We were trying to understand the nuisances of prescription drug monitoring programs, and there are a lot of differences between states and changes over time. Policy surveillance was useful in cataloging that information, which we then combined with outcome data and used in analysis of how effective PDMPs have been.